Brief: Qlife Provides Update On Operational Progress In China

Qlife Holding AB

07/01/2025 08:01

Jan 7 (Reuters) - Qlife Holding AB  QLIFE.ST :
    * PROVIDES UPDATE ON OPERATIONAL PROGRESS IN CHINA
    * STRATEGIC PARTNER IN CHINA, HIPRO BIOTECHNOLOGY, HAS
SUCCESSFULLY COMPLETED INITIAL CLINICAL STUDY WITH EXCELLENT
RESULTS
    * FINAL PHASE OF CLINICAL STUDY IS EXPECTED TO CONCLUDE IN
FIRST
HALF OF 2025

Source text:  ID:nWkr28zxmB 
Further company coverage:  QLIFE.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))